Company news
Akebia Therapeutics, Inc. news in 2019
Akebia Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Akebia Secures $100 Million Non-Dilutive Term Loan Financing; Reports Third Quarter 2019 Financial Results
November 11, 2019
Akebia Announces Positive 52-week Efficacy and Safety Data for Vadadustat from Two Pivotal Phase 3 Studies in Japanese Patients with Anemia Due to Chronic Kidney Disease
November 8, 2019
Akebia Announces Nine Abstracts Accepted for Presentation at the American Society of Nephrology Kidney Week 2019 Annual Meeting
October 23, 2019
Akebia Files Lawsuit Against CMS for 2018 Action Rescinding Medicare Part D Coverage of FDA-Approved Auryxia® for its Iron Deficiency Anemia Indication and Imposing a Prior Authorization Requirement for its Hyperphosphatemia Indication
October 14, 2019
Decks in 2019
- Investor Presentation (June 2019)
Investor deck · 26 slides · Jun 4, 2019
- 37th Annual J.P. Morgan Healthcare Conference 2019
Conference · 28 slides · Jan 7, 2019